A Validated Liquid Chromatographic Method for Berberine Analysis in Tissue and Application.

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Analytical Chemistry
• Biochemistry

Background:

• Berberine (BB) is a natural compound with potential therapeutic applications.
• Understanding BB's tissue distribution and the impact of drug interactions is crucial for its clinical use.
• Glycyrrhetinic acid (GA) is being investigated as a P-glycoprotein (P-gp) inhibitor that may affect BB bioavailability.

Purpose of the Study:

• To develop and validate simple, rapid high-performance liquid chromatography (HPLC) methods for berberine (BB) determination in rat tissues.
• To evaluate the effect of glycyrrhetinic acid (GA) on the oral bioavailability and tissue distribution of BB in rats.
• To investigate potential drug-drug interactions between GA and BB in vivo.

Main Methods:

• Development of rapid high-performance liquid chromatography (HPLC) methods for BB quantification.
• Acetonitrile-based extraction of BB from various rat tissues (liver, kidney, spleen).
• Validation of analytical methods for precision, accuracy, and stability (long-term, freeze-thaw, preparative).

Main Results:

• The developed HPLC methods demonstrated high precision and accuracy (<10% variability) and suitable stability for in vivo studies.
• BB tissue distribution exhibited a saturated model, with concentrations plateauing above 200 mg/kg dose.
• BB concentrations were highest in the liver, followed by the kidney and spleen, indicating preferential accumulation in the liver.

Conclusions:

• Validated rapid HPLC methods enable accurate BB quantification in rat tissues.
• GA did not significantly alter BB tissue distribution at the tested doses, suggesting limited impact on BB's oral bioavailability via this route.
• BB exhibits saturable tissue distribution, with the liver being the primary site of accumulation.